Suppr超能文献

经巩膜离子电渗疗法中屏障及屏障改变的研究

Examination of barriers and barrier alteration in transscleral iontophoresis.

作者信息

Molokhia Sarah A, Jeong Eun-Kee, Higuchi William I, Li S Kevin

机构信息

Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah 84112, USA.

出版信息

J Pharm Sci. 2008 Feb;97(2):831-44. doi: 10.1002/jps.21003.

Abstract

The flux enhancing mechanisms of transscleral iontophoresis are not well understood. The objective of the present study was to investigate the ocular barrier and barrier alterations in transscleral iontophoretic delivery with magnetic resonance imaging (MRI). Experiments involving constant current transscleral iontophoresis of 2 mA (current density 10 mA/cm(2)) and subconjunctival injection were conducted with rabbits in vivo and postmortem and with excised sclera in side-by-side diffusion cells in vitro. The postmortem and in vitro experiments were expected to be helpful in clarifying the importance of vascular clearance and other transport barriers in transscleral iontophoresis. Manganese ion (Mn(2+)) and manganese ethylenediaminetetraacetic acid complex (MnEDTA(2-)) were the model permeants. The results show that pretreatment of the eye with an electric field by iontophoresis enhanced subconjunctival delivery of the permeants to the anterior segment of the eye in vivo. This suggests that electric field-induced barrier alterations can be an important absorption enhancing mechanism of ocular iontophoresis. Penetration enhancement was magnified in the postmortem experiments with larger amounts of the permeants delivered into the eye and to the back of the eye. The different results observed in the in vivo and postmortem studies can be attributed to ocular clearance in ocular delivery.

摘要

经巩膜离子电渗疗法的通量增强机制尚未完全明确。本研究的目的是利用磁共振成像(MRI)研究经巩膜离子电渗给药过程中的眼部屏障及屏障改变。在兔体内、死后及体外并排扩散池中使用切除的巩膜进行了涉及2 mA(电流密度10 mA/cm²)恒流经巩膜离子电渗疗法和结膜下注射的实验。预期死后及体外实验有助于阐明经巩膜离子电渗疗法中血管清除及其他转运屏障的重要性。锰离子(Mn²⁺)和乙二胺四乙酸锰络合物(MnEDTA²⁻)为模型渗透剂。结果表明,通过离子电渗疗法用电场对眼部进行预处理可增强体内结膜下渗透剂向眼前段的递送。这表明电场诱导的屏障改变可能是眼部离子电渗疗法重要的吸收增强机制。在死后实验中,随着更多渗透剂递送至眼内及眼后,渗透增强作用被放大。体内和死后研究中观察到的不同结果可归因于眼部给药中的眼部清除作用。

相似文献

7
Transscleral passive and iontophoretic transport: theory and analysis.经巩膜被动和离子导入传输:理论与分析。
Expert Opin Drug Deliv. 2018 Mar;15(3):283-299. doi: 10.1080/17425247.2018.1406918. Epub 2017 Dec 5.

引用本文的文献

3
Protein and polypeptide mediated delivery to the eye.蛋白质和多肽介导的眼部递药。
Adv Drug Deliv Rev. 2022 Sep;188:114441. doi: 10.1016/j.addr.2022.114441. Epub 2022 Jul 9.
4
The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.局部眼用药物在靶向眼后部方面的新作用
Ophthalmol Ther. 2021 Sep;10(3):465-494. doi: 10.1007/s40123-021-00365-y. Epub 2021 Jul 4.
6
Ocular Biodistribution Studies using Molecular Imaging.使用分子成像技术的眼部生物分布研究
Pharmaceutics. 2019 May 16;11(5):237. doi: 10.3390/pharmaceutics11050237.
7
MRI study of subconjunctival and intravitreal injections.MRI 研究眼表面下和玻璃体内注射。
J Pharm Sci. 2012 Jul;101(7):2353-63. doi: 10.1002/jps.23127. Epub 2012 Mar 30.
9
10
New techniques for drug delivery to the posterior eye segment.向眼后段递药的新技术。
Pharm Res. 2010 Apr;27(4):530-43. doi: 10.1007/s11095-009-0042-9. Epub 2010 Feb 13.

本文引用的文献

4
Membrane electroporation theories: a review.膜电穿孔理论综述
Med Biol Eng Comput. 2006 Mar;44(1-2):5-14. doi: 10.1007/s11517-005-0020-2.
7
Ocular drug delivery.眼部药物递送
Expert Opin Drug Deliv. 2006 Mar;3(2):275-87. doi: 10.1517/17425247.3.2.275.
8
Iontophoresis: a non-invasive ocular drug delivery.离子电渗疗法:一种非侵入性眼部给药方式。
J Control Release. 2006 Feb 21;110(3):479-89. doi: 10.1016/j.jconrel.2005.09.049. Epub 2005 Dec 15.
9
Periocular routes for retinal drug delivery.视网膜药物递送的眼周途径。
Expert Opin Drug Deliv. 2004 Nov;1(1):99-114. doi: 10.1517/17425247.1.1.99.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验